EUZ.DE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:35):

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide...

Stats
Dagens volum	33 372.00
Gjennomsnittsvolum	58 112.00
Markedsverdi	764.74M
EPS	€0 ( 2024-03-21 )
Neste inntjeningsdato	( €0 ) 2024-05-13
Last Dividend	€0.500 ( 2023-06-08 )
Next Dividend	€0 ( N/A )
P/E	25.15
ATR14	€0.0490 (0.13%)

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.07 (neutral)

Signal:(45.799) Neutral

Eckert & Ziegler Strahlen Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Eckert & Ziegler Strahlen Korrelasjon - Valuta/Råvare

0.48
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.22
( neutral )

0.15
( neutral )

-0.54
( weak negative )

Eckert & Ziegler Strahlen Økonomi

Annual	2023
Omsetning:	€246.09M
Bruttogevinst:	€116.34M (47.28 %)
EPS:	€1.260

FY	2023
Omsetning:	€246.09M
Bruttogevinst:	€116.34M (47.28 %)
EPS:	€1.260

FY	2022
Omsetning:	€222.26M
Bruttogevinst:	€106.78M (48.04 %)
EPS:	€1.410

FY	2021
Omsetning:	€180.44M
Bruttogevinst:	€91.08M (50.48 %)
EPS:	€1.670

Financial Reports:

No articles found.

Eckert & Ziegler Strahlen Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.500 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Eckert & Ziegler Strahlen Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.49 - Stable (10.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.113	2002-05-27
Last Dividend	€0.500	2023-06-08
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	€5.52	--
Avg. Dividend % Per Year	0.00%	--
Score	3.1	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.49
Div. Directional Score	7.98	--

Next Divdend (Est)
(2024-05-27)

€0.506 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.10

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PUM.DE	Ex Dividend Junior	2023-05-25	Annually	0.00%
BMW.DE	Ex Dividend Junior	2023-05-12	Annually	0.00%
INN1.DE	Ex Dividend Junior	2023-08-07	Semi-Annually	0.00%
SWF.DE	Ex Dividend Junior	2023-09-01	Quarterly	0.00%
CVS.DE	Ex Dividend Knight	2023-10-19	Quarterly	0.00%
LUS1.DE	Ex Dividend Junior	2023-06-23	Annually	0.00%
2M6.DE	Ex Dividend Knight	2023-09-21	Quarterly	0.00%
VFP.DE	Ex Dividend Junior	2023-09-08	Quarterly	0.00%
ENI.F	Ex Dividend Knight	2023-11-20	Semi-Annually	0.00%
NVJP.DE	Ex Dividend Knight	2023-08-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.107	1.500	7.86	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0599	1.200	8.00	9.61	[0 - 0.3]
returnOnEquityTTM	0.120	1.500	9.78	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.79	0.800	1.040	0.832	[1 - 3]
quickRatioTTM	2.31	0.800	1.089	0.871	[0.8 - 2.5]
cashRatioTTM	0.813	1.500	6.60	9.90	[0.2 - 2]
debtRatioTTM	0.128	-1.500	7.86	-10.00	[0 - 0.6]
interestCoverageTTM	11.64	1.000	6.80	6.80	[3 - 30]
operatingCashFlowPerShareTTM	2.28	2.00	9.24	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.015	2.00	9.49	10.00	[0 - 20]
debtEquityRatioTTM	0.253	-1.500	8.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.473	1.000	5.45	5.45	[0.2 - 0.8]
operatingProfitMarginTTM	0.189	1.000	8.22	8.22	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.842	1.000	6.43	6.43	[0.2 - 2]
assetTurnoverTTM	0.560	0.800	9.60	7.68	[0.5 - 2]
Total Score				11.48

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	29.07	1.000	7.17	0	[1 - 100]
returnOnEquityTTM	0.120	2.50	9.86	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.015	2.00	9.66	10.00	[0 - 30]
dividendYielPercentageTTM	1.362	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.28	2.00	9.24	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-7.78	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.193	1.000	7.69	0	[0.1 - 0.5]
Total Score				4.49

Eckert & Ziegler Strahlen

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.